Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111745 · ClinicalTrials.gov registry record
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 730
- Enrollment target
NCT03111745: Completed study, sponsored by National Cancer Institute (NCI).
NCT03111745 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 730 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111745 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 730 participants
- Enrollment target
Study Summary
Background: Some blood and immune disorders can be helped with HSCT. This is allogeneic hematopoietic stem cell transplantation. The person who gets the stem cells has their immune system suppressed. This is done to help prevent their body from rejecting the transplant. During this time, the person is at a high risk to get viral infections. Researchers want to study the records of people who had transplants a few years ago. They want to look at how often certain viral complications happened. Objective: To study how often certain viral complications occurred after HSCT and what risks factors were involved. Eligibility: Records will be reviewed. No participants will be contacted. Design: Researchers will review medical records from the NIH Clinical Center. The records will be from people who had HSCT between 2010 and 2015 when they were between 4 and 85 years old. They already gave consent for their data to be studied. Data collected will include: Vital statistics like age and sex Viral status of the recipient and donor Reason for transplant Transplant details How the immune system recovered after transplant If the recipient got graft versus host disease Any infections Overall survival
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 730 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2020-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03111745
The ClinicalTrials.gov registry entry for NCT03111745 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 730 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03111745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03111745 about?
NCT03111745 is a clinical study titled "Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010". Background: Some blood and immune disorders can be helped with HSCT. This is allogeneic hematopoietic stem cell transplantation. The person who gets the stem cells has their immune system suppressed. This is done to help prevent their body from rejecting the transplant. During this time, the person...
What is the current status of trial NCT03111745?
This trial is currently completed. The enrollment target is 730 participants. The study started on 2017-04-13. Estimated completion is 2020-02-18.
Who is sponsoring clinical trial NCT03111745?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.